William Mack & Associates
RMD icon

William Mack & Associates’s ResMed RMD Stock Holding History

William Mack & Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.11K Buy
+5
New +$1.09K ﹤0.01% 704

Other funds holding RMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

William Mack & Associates's RMD Position: Q3 2026 in Review

William Mack & Associates opened a new position in ResMed (RMD) in Q3 2026: 5 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #704 among its holdings.

741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • William Mack & Associates held 5 shares of ResMed worth $1.11K as of Q3 2026.
  • ResMed was a new William Mack & Associates position in Q3 2026.
  • ResMed made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #704 holding.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.